33644054|t|Plasmalogen-Based Liquid Crystalline Multiphase Structures Involving Docosapentaenoyl Derivatives Inspired by Biological Cubic Membranes.
33644054|a|Structural properties of plasmenyl-glycerophospholipids (plasmalogens) have been scarcely studied for plasmalogens with long polyunsaturated fatty acid (PUFA) chains, despite of their significance for the organization and functions of the cellular membranes. Elaboration of supramolecular assemblies involving PUFA-chain plasmalogens in nanostructured mixtures with lyotropic lipids may accelerate the development of nanomedicines for certain severe pathologies (e.g., peroxisomal disorders, cardiometabolic impairments, and neurodegenerative Alzheimer's and Parkinson's diseases). Here, we investigate the spontaneous self-assembly of bioinspired, custom-produced docosapentaenoyl (DPA) plasmenyl (ether) and ester phospholipids in aqueous environment (pH 7) by synchrotron small-angle X-ray scattering (SAXS) and cryogenic transmission electron microscopy (cryo-TEM). A coexistence of a liquid crystalline primitive cubic Im3m phase and an inverted hexagonal (HII) phase is observed for the DPA-ethanolamine plasmalogen (C16:1p-22:5n6 PE) derivative. A double-diamond cubic Pn3m phase is formed in mixed assemblies of the phosphoethanolamine plasmalogen (C16:1p-22:5n6 PE) and monoolein (MO), whereas a coexistence of cubic and lamellar liquid crystalline phases is established for the DPA-plasmenyl phosphocholine (C16:1p-22:5n6 PC)/MO mixture at ambient temperature. The DPA-diacyl phosphoinositol (22:5n6-22:5n6 PI) ester lipid displays a propensity for a lamellar phase formation. Double membrane vesicles and multilamellar onion topologies with inhomogeneous distribution of interfacial curvature are formed upon incorporation of the phosphoethanolamine plasmalogen (C16:1p-22:5n6 PE) into dioleoylphosphocholine (DOPC) bilayers. Nanoparticulate formulations of plasmalogen-loaded cubosomes, hexosomes, and various multiphase cubosome- and hexosome-derived architectures and mixed type nano-objects (e.g., oil droplet-embedding vesicles or core-shell particles with soft corona) are produced with PUFA-chain phospholipids and lipophilic antioxidant-containing membrane compositions that are characterized by synchrotron SAXS and cryo-TEM imaging. The obtained multiphase nanostructures reflect the changes in the membrane curvature induced by the inclusion of DPA-based PE and PC plasmalogens, as well as DPA-PI ester derivative, and open new opportunities for exploration of these bioinspired nanoassemblies.
33644054	0	11	Plasmalogen	Chemical	MESH:D010955
33644054	69	85	Docosapentaenoyl	Chemical	-
33644054	163	193	plasmenyl-glycerophospholipids	Chemical	-
33644054	195	207	plasmalogens	Chemical	MESH:D010955
33644054	240	252	plasmalogens	Chemical	MESH:D010955
33644054	263	289	polyunsaturated fatty acid	Chemical	MESH:D005231
33644054	291	295	PUFA	Chemical	MESH:D005231
33644054	448	452	PUFA	Chemical	MESH:D005231
33644054	459	471	plasmalogens	Chemical	MESH:D010955
33644054	514	520	lipids	Chemical	MESH:D008055
33644054	607	628	peroxisomal disorders	Disease	MESH:D018901
33644054	630	657	cardiometabolic impairments	Disease	MESH:D024821
33644054	681	717	Alzheimer's and Parkinson's diseases	Disease	MESH:D010300
33644054	803	867	docosapentaenoyl (DPA) plasmenyl (ether) and ester phospholipids	Chemical	-
33644054	1131	1159	DPA-ethanolamine plasmalogen	Chemical	-
33644054	1165	1170	1p-22	Chromosome	1
33644054	1262	1293	phosphoethanolamine plasmalogen	Chemical	-
33644054	1299	1304	1p-22	Chromosome	1
33644054	1317	1326	monoolein	Chemical	MESH:C005953
33644054	1426	1454	DPA-plasmenyl phosphocholine	Chemical	-
33644054	1460	1465	1p-22	Chromosome	1
33644054	1513	1570	DPA-diacyl phosphoinositol (22:5n6-22:5n6 PI) ester lipid	Chemical	-
33644054	1779	1810	phosphoethanolamine plasmalogen	Chemical	-
33644054	1816	1821	1p-22	Chromosome	1
33644054	1835	1857	dioleoylphosphocholine	Chemical	-
33644054	1859	1863	DOPC	Chemical	-
33644054	1907	1918	plasmalogen	Chemical	MESH:D010955
33644054	2051	2054	oil	Chemical	MESH:D009821
33644054	2142	2146	PUFA	Chemical	MESH:D005231
33644054	2153	2166	phospholipids	Chemical	MESH:D010743
33644054	2405	2409	DPA-	Chemical	-
33644054	2415	2417	PE	Chemical	-
33644054	2422	2424	PC	Chemical	MESH:C053518
33644054	2425	2437	plasmalogens	Chemical	MESH:D010955
33644054	2450	2462	DPA-PI ester	Chemical	-
33644054	Association	MESH:D005231	MESH:D024821
33644054	Association	MESH:D005231	MESH:D010300
33644054	Association	MESH:D010955	MESH:D018901
33644054	Association	MESH:D010955	MESH:D024821
33644054	Association	MESH:D005231	MESH:D018901
33644054	Association	MESH:D005231	MESH:D010955
33644054	Association	MESH:D010955	MESH:D010300

